Question: As of August 2016, what was the market capitalisation of the company that developed the drug Losmapimod?

Context paragraphs:
GlaxoSmithKline: The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index.  As of August 2016 it had a market capitalisation of £81 billion (around $107 billion), the fourth largest on the London Stock Exchange.  It has a secondary listing on the New York Stock Exchange.

All Share Price Index: The All Share Price Index is one of the principal stock indices of the Colombo Stock Exchange in Sri Lanka.  ASPI measures the movement of share prices of all listed companies.  It is based on market capitalisation.  Weighting of shares is conducted in proportion to the issued ordinary capital of the listed companies, valued at current market price (i.e. market capitalisation).  The base year is 1985, and the base value of the index is 100.  This is the longest and the broadest measure of the Sri Lankan Stock market.

NZX 50 Index: The NZX 50 Index (NZ50) is the main stock market index in New Zealand.  It comprises the 50 biggest stocks by free-float market capitalisation trading on the New Zealand Stock Market (NZSX).  The calculation of the free-float capitalisation excludes blocks of shares greater than 20% and blocks between 5% and 20% that are considered strategic.

JSE Limited: JSE Limited (previously the JSE Securities Exchange and the Johannesburg Stock Exchange) is the oldest existing and largest stock exchange in Africa.  It is situated at the corner of Maude Street and Gwen Lane in Sandton, Johannesburg, South Africa.  In 2003 the JSE had an estimated 472 listed companies and a market capitalisation of US$182.6 billion (€158 billion), as well as an average monthly traded value of US$6.399 billion (€5.5 billion).  As of 31 December 2013, the market capitalisation of the JSE was at US$1,007 billion.

National Australia Bank: National Australia Bank (abbreviated NAB, branded nab) is one of the four largest financial institutions in Australia in terms of market capitalisation, earnings and customers.  NAB was ranked 21st largest bank in the world measured by market capitalisation and 41st largest bank in the world as measured by total assets in 2014, falling to 49th largest in March 2016.  s of November 2014 NAB operated 1,590 branches and service centres; and 4,412ATMs across Australia, New Zealand and Asia serving 12.7 million customers.

Losmapimod: Losmapimod (GW856553X) is a drug developed by GlaxoSmithKline which acts as a selective inhibitor of the enzyme family known as p38 mitogen-activated protein kinases.

Bao Viet Holdings: Bao Viet (also Bao Viet Holdings Vietnamese: "Tập đoàn Tài chính-Bảo hiểm Bảo Việt" ) is the largest Vietnamese insurance company and Vietnam's seventh largest listed company by market capitalisation.  It is state-owned and has a strategic partnership with HSBC, which also holds 18% of Bao Viet's shares.  HSBC is, however, soon to be replaced by Sumitomo Life.  Besides various insurance products, Bao Viet has diversified into stock market trading, fond management and real estate.  It also has subsidiaries in banking, hotels and construction.  Bao Viet has been losing market shares in recent years and has also been making losses in the insurance sector since 2009.

Stock Exchange of Mauritius: The Stock Exchange of Mauritius (SEM) (French: "Bourse de Maurice" ; Hindi: मॉरीशस के स्टॉक एक्सचेंज ; ) is an organization responsible for the operation of Mauritius's primary stock exchange located at Port Louis.  The SEM operates two markets: the Official Market and the Development & Enterprise Market (DEM).  There are 40 companies listed on the Official Market representing a Market Capitalization of nearly 5.3 billion, the DEM presently has 48 companies listed with a market capitalisation of nearly 1.5 billion as at 31 July 2012.  SEM is one of the leading Exchanges in Africa and a member of the World Federation of Exchanges.

Ooredoo Oman: Ooredoo Oman (formerly Nawras) is an Omani telecommunications company owned by Ooredoo (formerly the Qtel Group).  It is the Sultanate’s first privately owned telecommunications company, and serves two million customers as of August 2010.  It sells voice and data services over, among others, 2.75G, 3G+, WiMAX and fibre.  Since 2010, it has been listed at the Muscat Securities Market, and is the fourth largest telecom company by market capitalisation.

Cavalier Corporation: Cavalier Corporation Limited is a New Zealand company specializing in the manufacturer of broadloom wool carpet.  Floated in 1984, the company was once included in the NZX 50 share index, as one of New Zealand's 50 largest public companies.  As of December 2015 Cavalier had a market capitalisation of just under NZ$42 million, down from $167 million in May 2010.  It left the NZX50 due to lack of market capitalisation in January 2013.

Supporting paragraphs: Losmapimod GlaxoSmithKline
Answer: £81 billion